(Q39450580)

English

The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

scientific article published on 3 December 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury (English)

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

0 references

traumatic brain injury

0 references

Haleema Shakur-Still

object named as

Haleema Shakur

1

0 references

10

object named as

Chris Frost

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

20

object named as

Ian Roberts

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

7

object named as

Yashbir Dewan

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Bennie Hartzenberg

11

object named as

Bennie Hartzenberg

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Francisco Murillo-Cabezas

13

object named as

Francisco Murillo-Cabezas

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

4

object named as

Laura Balica

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Ramalingam R Ravi

15

object named as

Ramalingam R Ravi

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

author name string

Peter Andrews

2

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Toomas Asser

3

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Cristian Boeriu

5

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Juan Diego Ciro Quintero

6

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Patrick Druwé

8

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Olivia Fletcher

9

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Jorge Mejia Mantilla

12

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Jan Pachl

14

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Indrek Rätsep

16

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Cristina Sampaio

17

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Manmohan Singh

18

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Petr Svoboda

19

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

publication date

3 December 2009

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

10

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

109

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

copyright license

Creative Commons Attribution 2.0 Generic

1 December 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Beta-2 receptor antagonists for traumatic brain injury: a systematic review of controlled trials in animal models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794266

12 September 2017

Bradykinin beta-2 receptor antagonists for acute traumatic brain injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794266

12 September 2017

Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794266

12 September 2017

Contribution of edema and cerebral blood volume to traumatic brain swelling in head-injured patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794266

12 September 2017

Vasomotor and permeability effects of bradykinin in the cerebral microcirculation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794266

25 September 2017

LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794266

15 June 2018

Brain edema: pathogenesis and therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794266

15 June 2018

Serious adverse events in academic critical care research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794266

21 August 2018

A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794266

21 August 2018

LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces brain edema and improves long-term neurological function recovery after closed head trauma in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2794266

21 August 2018

Therapeutical efficacy of a novel non-peptide bradykinin B2 receptor antagonist on brain edema formation and ischemic tissue damage in focal cerebral ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19958521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*

1 reference

https://pubmed.ncbi.nlm.nih.gov/19958521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1745-6215-10-109

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1745-6215-10-109

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39450580&oldid=2202892482"